Sakurasaku Plus
7097
Timee
215A
Wintest
6721
Heartseed
219A
Raksul
4384
(FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 41.00%17.69B | 31.70%4.54B | 21.63%4.73B | 60.58%4.7B | 62.99%3.72B | 70.16%12.55B | 57.13%3.45B | 75.40%3.89B | 91.76%2.92B | 59.03%2.28B |
Cost of revenue | 30.73%12.88B | 22.78%3.47B | 17.77%3.46B | 47.09%3.37B | 43.52%2.58B | 72.51%9.85B | 56.91%2.83B | 74.44%2.94B | 100.31%2.29B | 66.15%1.8B |
Gross profit | 78.58%4.81B | 72.41%1.07B | 33.47%1.28B | 109.30%1.33B | 135.55%1.14B | 62.08%2.69B | 58.15%620.07M | 78.44%957.13M | 66.14%634.29M | 37.13%483.1M |
Operating expense | 48.45%3.54B | 14.34%962.1M | 21.92%922.71M | 94.06%852.91M | 131.92%798.36M | 82.68%2.38B | 147.59%841.42M | 118.68%756.84M | 36.89%439.52M | 15.94%344.23M |
Staff costs | 41.81%1.31B | ---- | ---- | ---- | ---- | 52.43%925.87M | ---- | ---- | ---- | ---- |
Selling and administrative expenses | 80.67%790.26M | ---- | ---- | ---- | ---- | 139.48%437.41M | ---- | ---- | ---- | ---- |
-General and administrative expense | 80.67%790.26M | ---- | ---- | ---- | ---- | 139.48%437.41M | ---- | ---- | ---- | ---- |
Research and development costs | -39.34%12.38M | ---- | ---- | ---- | ---- | 98.29%20.4M | ---- | ---- | ---- | ---- |
Other operating expenses | 42.28%1.42B | ---- | ---- | ---- | ---- | 98.25%998.32M | ---- | ---- | ---- | ---- |
Operating profit | 308.20%1.28B | 148.32%106.96M | 77.13%354.77M | 143.70%474.68M | 144.53%339.57M | -12.84%312.59M | -523.77%-221.35M | 5.25%200.29M | 220.87%194.78M | 150.76%138.87M |
Net non-operating interest income (expenses) | -36.73%-40.53M | -25.90%-12.25M | -23.91%-10.09M | -24.71%-9.24M | -105.18%-8.96M | -141.21%-29.65M | -106.52%-9.73M | -55.43%-8.15M | -502.20%-7.41M | -293.60%-4.37M |
Non-operating interest income | 68.78%319K | 70.63%244K | 58.82%27K | -4.35%22K | 333.33%26K | 67.26%189K | 266.67%143K | -52.78%17K | -11.54%23K | -50.00%6K |
Non-operating interest expense | 36.93%40.85M | 26.55%12.49M | 23.99%10.12M | 24.62%9.26M | 105.49%8.98M | 140.54%29.83M | 107.83%9.87M | 54.69%8.16M | 491.56%7.43M | 289.92%4.37M |
Net investment income | -31.94%1.98M | -97.70%16K | 20.23%208K | 0 | -1.23%1.76M | 39.34%2.92M | 633.68%697K | 343.59%173K | 19.00%263K | 2.59%1.78M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 92.93%-73K | 0 | 0 | 101.76%7K | -80K | -105.46%-1.03M | -2,737.50%-454K | -100.93%-181K | -398K | 0 |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -98.09%29.3M | 828.95%22.46M | -175.49%-1.97M | -99.30%10.74M | -7,259.26%-1.93M | 5,370.26%1.53B | 85.79%-3.08M | -537.50%-714K | 21,223.46%1.54B | 2,800.00%27K |
Less:Restructuring and mergern&acquisition | --0 | --0 | --0 | ---- | ---- | ---1.54B | --0 | --0 | ---- | ---- |
Less:Other special charges | -1,588.81%-19.3M | -3,319.38%-12.46M | 175.49%1.97M | -4,936.04%-10.74M | 7,259.26%1.93M | -84.15%1.3M | -51.20%387K | 537.50%714K | -96.95%222K | -2,800.00%-27K |
Less:Write off | -471.20%-10M | ---- | ---- | ---- | ---- | -87.10%2.69M | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -19.57%103.34M | -76.45%7.72M | -39.53%44.99M | 129.16%16.69M | 142.17%33.94M | 336.97%128.48M | 143.50%32.78M | 919.53%74.41M | 77.28%7.28M | 209.04%14.02M |
Income before tax | -29.56%1.37B | 162.10%124.9M | 45.93%387.91M | -71.51%492.87M | 142.34%364.3M | 428.99%1.94B | -610.72%-201.14M | 25.56%265.83M | 2,986.22%1.73B | 148.32%150.33M |
Income tax | -34.70%275.39M | -177.97%-100.81M | 0.39%121.41M | 58.58%152.99M | 35.75%101.8M | 97.93%421.69M | 60.63%129.29M | 107.57%120.94M | 70.98%96.48M | 319.71%74.99M |
Net income | -28.14%1.09B | 168.31%225.72M | 83.94%266.5M | -79.19%339.87M | 248.43%262.51M | 885.12%1.52B | -703.79%-330.43M | -5.57%144.89M | 440,398.38%1.63B | 76.56%75.34M |
Net income continuous operations | -28.14%1.09B | 168.31%225.72M | 83.93%266.5M | -79.19%339.87M | 248.43%262.51M | 885.12%1.52B | -703.77%-330.43M | -5.57%144.89M | 439,214.52%1.63B | 76.56%75.34M |
Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to the company | -28.14%1.09B | 168.31%225.72M | 83.94%266.5M | -79.19%339.87M | 248.43%262.51M | 885.12%1.52B | -703.79%-330.43M | -5.57%144.89M | 440,398.38%1.63B | 76.56%75.34M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -28.14%1.09B | 168.31%225.72M | 83.94%266.5M | -79.19%339.87M | 248.43%262.51M | 885.12%1.52B | -703.79%-330.43M | -5.57%144.89M | 440,398.38%1.63B | 76.56%75.34M |
Gross dividend payment | ||||||||||
Basic earnings per share | -28.59%167.33 | 167.23%34.49 | 84.85%40.74 | -79.37%51.97 | 244.46%40.13 | 876.78%234.33 | -699.07%-51.3 | -7.55%22.04 | 360,014.29%251.94 | 75.45%11.65 |
Diluted earnings per share | -28.14%167.25 | 167.23%34.49 | 84.75%40.72 | -79.19%51.93 | 248.48%40.11 | 881.70%232.76 | -699.07%-51.3 | -6.09%22.04 | 356,671.43%249.6 | 76.53%11.51 |
Dividend per share | 75.00%35 | 75.00%35 | 0 | 0 | 0 | 33.33%20 | 33.33%20 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |